Common Shares Outstanding - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Common Shares Outstanding Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Common Shares Outstanding
€65m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Common Shares Outstanding
€139.2m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
9%
Nanobiotix SA
PAR:NANO
Common Shares Outstanding
€47.1m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
15%
Innate Pharma SA
PAR:IPH
Common Shares Outstanding
€80.9m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
Genfit SA
NASDAQ:GNFT
Common Shares Outstanding
€49.8m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
9%
Eurobio Scientific SA
PAR:ALERS
Common Shares Outstanding
€10.9m
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
14%

See Also

What is Gensight Biologics SA's Common Shares Outstanding?
Common Shares Outstanding
65m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Common Shares Outstanding amounts to 65m EUR.

What is Gensight Biologics SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
22%

Over the last year, the Common Shares Outstanding growth was 40%. The average annual Common Shares Outstanding growth rates for Gensight Biologics SA have been 17% over the past three years , 22% over the past five years .

Back to Top